Latest News
-
3 Bonus, 1:2 Split, 38 Dividends: Rs 1,915 Midcap IT Stock To Pay 360% Dividend After Q4 Profit Rises -
EU Finds No New ETO Cases in Indian Organic Exports Post-Dec 2020 -
1:5 Stock Split Approved: Defence Stock To Be Cheaper Soon, Shares Zoom 507% In 1-Yr -
Edelweiss Alternatives Expands Portfolio with Bengaluru's MMTP Projects Acquisition -
1:2 Split, 1:1 Bonus, Rs 28/Sh Dividend: Mahindra's IT Stock To Pay 560% Dividend; Check Record, Payment Dates -
Kotak Mahindra Bank Takes Steps to Address RBI's IT Compliance Issues -
IndiGo to Expand Fleet with Up to 100 Airbus A350 Wide-Body Aircraft -
Dimapur Businesses Announce Shutdown Over Rampant Illegal Taxation -
ICEA Proposes Semiconductor Design, Manufacturing as India's Strategic Sector -
RBI Mandates Gurugram's TalkCharge to Refund PPI Wallet Funds
Sun Pharma Shares Surge 13% On Buyback Plans
Shares of Sun Pharma gained on Friday after announcing that the company will consider share buyback at its board meeting on 17 March. Breaking its 5-day losing streak, the pharma company was among the top gainers on Nifty.
The stock rose 13 percent to an intraday high of Rs 401.50.
In a stock exchange filing, Sun Pharma said that a proposal for buy-back of fully paid-up equity shares including maximum amount, the maximum number of equity shares, mode of buy-back and other matters will be discussed at the board meeting in adherence with SEBI rules.
"In this connection, as per the Company's code of conduct for prevention of insider trading, the trading window for dealing or trading in securities of the Company will remain closed with immediate effect for all directors, designated persons and insiders and shall re-open after the expiry of 48 hours after the conclusion of the aforesaid Board Meeting," it added.
